Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 261-270 of 271 for Lung cancer

Edit search filters
  1. Therapeutic Drug Monitoring Of Pembrolizumab And Nivolumab To Determine Dosages For Cancer Treatment

    Rochester, MN

  2. The Circulating Cell-free Genome Atlas Study

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. A Study To Evaluate Fractionated Radiation Therapy Utilizing GRID Therapy For Locally-advanced Bulky Tumors

    Jacksonville, FL, Rochester, MN

  4. Cell Free DNA (Cfdna) Blood Assays For The Detection Of EGFR And Other Clinically Relevant Gene Mutations In Patients With Non-Small Cell Lung Cancer

    Rochester, MN

  5. Immune Responses In Prostate, Lung, Melanoma And Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) Or Brachytherapy

    Rochester, MN

  6. A Study Of Staging Procedures To Diagnose Malignant Pleural Mesothelioma

    Rochester, MN

  7. Chemotherapy Followed By Surgery And Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) For Patients With Malignant Pleural Mesothelioma

    Rochester, MN

  8. Neuroendocrine Tumors - Patient Reported Outcomes

    Rochester, MN

  9. A Study Of Performing Surgery For Resectable Malignant Pleural Mesothelioma After Radiation Therapy

    Rochester, MN

  10. Treating Highly Sensitized Patients on the Kidney Transplant Waiting List by Depleting Their B-cells Using Chimeric Antigen Receptor T Cells (CAR-T)

    Jacksonville, FL

.

Mayo Clinic Footer